Review: taking Levothroid and Rosuvastatin calcium together


Summary

Drug interactions are reported among people who take Levothroid and Rosuvastatin calcium together. This review analyzes the effectiveness and drug interactions between Levothroid and Rosuvastatin calcium. It is created by eHealthMe based on reports of 5,870 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Levothroid and Rosuvastatin calcium >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Levothroid

Levothroid has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. (latest outcomes from Levothroid 5,546 users)

Rosuvastatin Calcium

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in hyperlipidaemia. (latest outcomes from Rosuvastatin calcium 1,402 users)

On Jul, 26, 2016

5,870 people who take Levothroid, Rosuvastatin Calcium are studied.


Number of reports submitted per year:

Levothroid and Rosuvastatin calcium drug interactions.

Drug effectiveness over time:

Levothroid:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 25.0% - (4 of 16 people)
  • 6 - 12 months: 26.0% - (5 of 19 people)
  • 1 - 2 years: 30.0% - (11 of 36 people)
  • 2 - 5 years: 68.0% - (41 of 60 people)
  • 5 - 10 years: 60.0% - (48 of 80 people)
  • 10+ years: 80.0% - (125 of 155 people)
  • not specified: 100.0% - (4 of 4 people)
Rosuvastatin Calcium:
  • < 1 month: 0.0% - (0 of 7 people)
  • 1 - 6 months: 39.0% - (18 of 46 people)
  • 6 - 12 months: 50.0% - (20 of 40 people)
  • 1 - 2 years: 55.0% - (34 of 61 people)
  • 2 - 5 years: 70.0% - (76 of 108 people)
  • 5 - 10 years: 62.0% - (43 of 69 people)
  • 10+ years: 67.0% - (21 of 31 people)
  • not specified: 0.0% - (0 of 3 people)

Drug effectiveness by gender:

Levothroid:
  • female: 65.0% - (183 of 278 people)
  • male: 59.0% - (55 of 92 people)
Rosuvastatin Calcium:
  • female: 57.0% - (156 of 270 people)
  • male: 58.0% - (56 of 95 people)

Drug effectiveness by age:

Levothroid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 35.0% - (5 of 14 people)
  • 40-49: 50.0% - (24 of 48 people)
  • 50-59: 62.0% - (86 of 137 people)
  • 60+: 72.0% - (123 of 170 people)
Rosuvastatin Calcium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 2 people)
  • 30-39: 38.0% - (5 of 13 people)
  • 40-49: 60.0% - (24 of 40 people)
  • 50-59: 59.0% - (82 of 137 people)
  • 60+: 58.0% - (101 of 173 people)

Most common drug interactions over time *:

< 1 month:
  • myalgia
  • diarrhoea
  • headache
  • nausea
  • fatigue
  • febrile neutropenia
  • pain in extremity
  • arthralgia
  • dyspnoea
  • pneumonia
1 - 6 months:
  • myalgia
  • blood creatine phosphokinase increased
  • fatigue
  • arthralgia
  • asthenia
  • headache
  • low density lipoprotein increased
  • myopathy
  • dizziness
  • nausea
6 - 12 months:
  • fatigue
  • depression
  • myalgia
  • muscle weakness
  • pain
  • pain in extremity
  • weight gain
  • asthenia
  • blood creatinine increased
  • dyspnoea
1 - 2 years:
  • blood creatine phosphokinase increased
  • fatigue
  • myalgia
  • pain in extremity
  • depression
  • insomnia
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fluid retention
  • muscle spasms
  • muscle weakness
2 - 5 years:
  • dizziness
  • fatigue
  • insomnia
  • muscle pain
  • muscle spasms
  • pain
  • pain in extremity
  • platelet count decreased
  • weight gain
  • back pain
5 - 10 years:
  • diarrhea
  • runny nose
  • tinnitus
  • insomnia
  • muscle pain
  • dry skin
  • fatigue
  • headache
  • high blood pressure
  • shortness of breath
10+ years:
  • impotence
  • erectile dysfunction
  • insomnia
  • fatigue
  • chronic depression
  • drooling
  • incontinence
  • lack of strength, muscle weakness, weakness
  • dizziness
  • high blood pressure
not specified:
  • nausea
  • fatigue
  • pain
  • dyspnoea
  • dizziness
  • asthenia
  • myalgia
  • arthralgia
  • pain in extremity
  • headache

Most common drug interactions by gender *:

female:
  • nausea
  • fatigue
  • pain
  • myalgia
  • dizziness
  • dyspnoea
  • asthenia
  • arthralgia
  • pain in extremity
  • headache
male:
  • flushing
  • fatigue
  • dyspnoea
  • dizziness
  • renal failure acute
  • nausea
  • myalgia
  • malaise
  • myocardial infarction
  • asthenia

Most common drug interactions by age *:

0-1:
  • hypersensitivity
  • gait disturbance
  • myalgia
  • pain in extremity
  • blood cholesterol increased
  • gallbladder operation
  • sensation of foreign body
  • type 2 diabetes mellitus
  • anomaly of external ear congenital
  • anxiety
10-19:
  • asthenia
  • pain
  • rhabdomyolysis
20-29:
  • back pain
  • grand mal convulsion
  • acne
  • activities of daily living impaired
  • anticonvulsant drug level abnormal
  • apnoea
  • arthritis
  • asthma
  • biopsy liver abnormal
  • blood pressure increased
30-39:
  • nausea
  • weight increased
  • pulmonary embolism
  • hyperglycaemia
  • deep vein thrombosis
  • dehydration
  • fatigue
  • injection site irritation
  • injection site pain
  • vomiting
40-49:
  • nausea
  • pain
  • dyspnoea
  • myalgia
  • malaise
  • chest pain
  • headache
  • diarrhoea
  • arthralgia
  • oedema peripheral
50-59:
  • nausea
  • arthralgia
  • pain
  • fatigue
  • myalgia
  • oedema peripheral
  • headache
  • anxiety
  • depression
  • dyspnoea
60+:
  • fatigue
  • nausea
  • dyspnoea
  • dizziness
  • asthenia
  • myalgia
  • pain in extremity
  • pain
  • arthralgia
  • diarrhoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Levothroid and Rosuvastatin calcium?

Can you answer these questions?

More questions for: Levothroid, Rosuvastatin calcium

You may be interested in these reviews

More reviews for: Levothroid, Rosuvastatin calcium

On eHealthMe, Levothroid (levothyroxine sodium) is often used to treat hypothyroidism. Rosuvastatin calcium (rosuvastatin calcium) is often used to treat hyperlipidaemia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.